Harfst & Associates’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,964
| Closed | -$401K | – | 140 |
|
|
2021
Q1 | $401K | Sell |
1,964
-4,346
| -69% | -$887K | 0.12% | 116 |
|
|
2020
Q4 | $1.15M | Buy |
6,310
+1,747
| +38% | +$318K | 0.42% | 43 |
|
|
2020
Q3 | $763K | Buy |
4,563
+882
| +24% | +$147K | 0.32% | 50 |
|
|
2020
Q2 | $598K | Buy |
3,681
+2,431
| +194% | +$395K | 0.26% | 57 |
|
|
2020
Q1 | $216K | Buy |
1,250
+54
| +5% | +$9.33K | 0.11% | 91 |
|
|
2019
Q4 | $240K | Sell |
1,196
-17
| -1% | -$3.41K | 0.09% | 91 |
|
|
2019
Q3 | $256K | Buy |
1,213
+62
| +5% | +$13.1K | 0.11% | 85 |
|
|
2019
Q2 | $223K | Buy |
+1,151
| New | +$223K | 0.09% | 90 |
|
|
2019
Q1 | – | Sell |
-1,105
| Closed | -$207K | – | 96 |
|
|
2018
Q4 | $207K | Buy |
+1,105
| New | +$207K | 0.1% | 85 |
|